Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies

William L. Bakera University of Connecticut School of Pharmacy, Storrs, CT, USA;b Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA

https://orcid.org/0000-0003-2172-0931

Matthew S. Robertsb Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA

Youssef Bessadaa University of Connecticut School of Pharmacy, Storrs, CT, USA;b Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA

Kimberly S. Carotib Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA

Veronica Ashtonc Real World Value and Evidence, Janssen Scientific Affairs LLC, Titusville, NJ, USA

Brahim K. Bookhartc Real World Value and Evidence, Janssen Scientific Affairs LLC, Titusville, NJ, USA

Craig I. Colemana University of Connecticut School of Pharmacy, Storrs, CT, USA;b Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USACorrespondence[email protected]

https://orcid.org/0000-0003-4868-7158

show all

Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date